List of Saitama Medical University patents

List of Saitama Medical University patents

List of SentiAR patents

List of Avatier patents

List of Eargo patents

List of funding rounds for botkeeper

List of companies in Link VC's investment portfolio

Patents where

Current Assignee

Name

is

Saitama Medical University

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9521953 Measurement device and measurement method	Patent 9521953 was granted and assigned to Saitama Medical University on December, 2016 by the United States Patent and Trademark Office.	Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	9521953	December 20, 2016
	‌ US Patent 9873920 Method for evaluating side-effect onset risk in anticancer drug treatment, including detecting MUC4 gene polymorphism	Patent 9873920 was granted and assigned to Saitama Medical University on January, 2018 by the United States Patent and Trademark Office.	Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	9873920	January 23, 2018
	‌ US Patent 10370730 Detection method for mutation in 93rd amino acid of hepatitis C virus NS5A protein, and detection kit for mutation in 93rd amino acid of hepatitis C virus NS54 protein	Patent 10370730 was granted and assigned to Saitama Medical University on August, 2019 by the United States Patent and Trademark Office.	Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	10370730	August 6, 2019
	‌ US Patent 9868934 Method for producing pluripotent stem cells	Patent 9868934 was granted and assigned to Saitama Medical University on January, 2018 by the United States Patent and Trademark Office.	Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	9868934	January 16, 2018
	‌ US Patent 9856304 Peptide and application thereof	Patent 9856304 was granted and assigned to Saitama Medical University on January, 2018 by the United States Patent and Trademark Office.	Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	9856304	January 2, 2018
	‌ US Patent 9458210 Antibody reacting with native Cochlin-tomoprotein (CTP) and method for measuring CTP using same	Patent 9458210 was granted and assigned to Saitama Medical University on October, 2016 by the United States Patent and Trademark Office.		Saitama Medical University		United States Patent and Trademark Office	9458210	October 4, 2016
	‌ US Patent 10561679 Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drug	Patent 10561679 was granted and assigned to Saitama Medical University on February, 2020 by the United States Patent and Trademark Office.	Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	10561679	February 18, 2020
	‌ US Patent 8236758 Method of treatment of diabestes or reduction in pancreatic beta-cells	Patent 8236758 was granted and assigned to Saitama Medical University on August, 2012 by the United States Patent and Trademark Office.		Saitama Medical University		United States Patent and Trademark Office	8236758	August 7, 2012
	‌ US Patent 8993254 Methods for evaluating risk of mother's milk or food inducing an onset of atopic dermatitis, and mother's milk or food with reduced risk of inducing an onset of atopic dermatitis	Patent 8993254 was granted and assigned to Saitama Medical University on March, 2015 by the United States Patent and Trademark Office.		Saitama Medical University		United States Patent and Trademark Office	8993254	March 31, 2015
	‌ US Patent 10835551 Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drug		Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	10835551	November 17, 2020
	‌ US Patent 8781076 Phase controller	Patent 8781076 was granted and assigned to Saitama Medical University on July, 2014 by the United States Patent and Trademark Office.		Saitama Medical University		United States Patent and Trademark Office	8781076	July 15, 2014
	‌ US Patent 10851342 Method for producing pluripotent stem cells	Patent 10851342 was granted and assigned to Saitama Medical University on December, 2020 by the United States Patent and Trademark Office.	Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	10851342	December 1, 2020
	‌ US Patent 10809200 Test object visualizing device		Saitama Medical University	Saitama Medical University		United States Patent and Trademark Office	10809200	October 20, 2020

13 results

0 selected

13 results

0 selected